Consistent with LSCI findings, TNP@PCs significantly reduced the number of NeuN+TUNEL+ cells and dark-stained neurons with shrunken morphology, markedly improving cerebral ischemia outcomes (Fig. 6, G to J). This evidence concerns the gene RBFOX3 and Cerebral ischemia.